Epilepsy lifetime prevalence in Iran: a large population- based national survey

Abstract Epilepsy has garnered increased public health focus because patients who suffer from epilepsy experience pronounced and persistent health and socioeconomic disparities despite treatment and care advances. The epidemiology of epilepsy is diverse in different countries and regions. This natio...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, Farshid Alaeddini, Akram Esfandani, Seyed Hamidreza Mirbehbahani, Taher Doroudi, Pirhossein Kolivand, Parviz Bahrami, Hadi Kazemi
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/9ddb771057bb4126859a047085d440bf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9ddb771057bb4126859a047085d440bf
record_format	dspace
spelling	oai:doaj.org-article:9ddb771057bb4126859a047085d440bf2021-12-02T15:38:23ZEpilepsy lifetime prevalence in Iran: a large population- based national survey10.1038/s41598-021-89048-z2045-2322https://doaj.org/article/9ddb771057bb4126859a047085d440bf2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89048-zhttps://doaj.org/toc/2045-2322Abstract Epilepsy has garnered increased public health focus because patients who suffer from epilepsy experience pronounced and persistent health and socioeconomic disparities despite treatment and care advances. The epidemiology of epilepsy is diverse in different countries and regions. This nationwide population-based cross-sectional study was conducted to determine the life time prevalence and health related factors of epilepsy for the first time in Iran through a two-phase door-to-door survey method. In phase I, a screening for epilepsy was performed on 68,035 people. Then in phase II, after the neurological evaluation of participants and reviewing medical records, 1130 subjects with epilepsy was confirmed. The life time prevalence of epilepsy was achieved to be 16.6 per 1000 people (95% CI 15.4–17.8) with the average age onset 19.1 ± 21.1 (active prevalence 9.5 per 1000 people). Focal seizure (59.3%), generalized epilepsy (38%) and unknown types of epilepsy (2.7%) were detected among participants. The overall life time prevalence of febrile convulsion was 4.1 per 1000 people. The frequency of attacks per year and per month were 3.0 ± 1.6 and 0.5 ± 0.1, respectively. Age-specific life time prevalence was highest among the age group of 15–19 years old [32.7 per 1000 persons (95% CI 29.1–36.8)] and it was higher in male (53.8%) than female (46.2%) participants. Our results showed that the life time prevalence of epilepsy in Iran is higher than worldwide average.Hossein PakdamanAli Amini HarandiKoroush GharagozliFarshid AlaeddiniAkram EsfandaniSeyed Hamidreza MirbehbahaniTaher DoroudiPirhossein KolivandParviz BahramiHadi KazemiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Hossein Pakdaman Ali Amini Harandi Koroush Gharagozli Farshid Alaeddini Akram Esfandani Seyed Hamidreza Mirbehbahani Taher Doroudi Pirhossein Kolivand Parviz Bahrami Hadi Kazemi Epilepsy lifetime prevalence in Iran: a large population- based national survey
description	Abstract Epilepsy has garnered increased public health focus because patients who suffer from epilepsy experience pronounced and persistent health and socioeconomic disparities despite treatment and care advances. The epidemiology of epilepsy is diverse in different countries and regions. This nationwide population-based cross-sectional study was conducted to determine the life time prevalence and health related factors of epilepsy for the first time in Iran through a two-phase door-to-door survey method. In phase I, a screening for epilepsy was performed on 68,035 people. Then in phase II, after the neurological evaluation of participants and reviewing medical records, 1130 subjects with epilepsy was confirmed. The life time prevalence of epilepsy was achieved to be 16.6 per 1000 people (95% CI 15.4–17.8) with the average age onset 19.1 ± 21.1 (active prevalence 9.5 per 1000 people). Focal seizure (59.3%), generalized epilepsy (38%) and unknown types of epilepsy (2.7%) were detected among participants. The overall life time prevalence of febrile convulsion was 4.1 per 1000 people. The frequency of attacks per year and per month were 3.0 ± 1.6 and 0.5 ± 0.1, respectively. Age-specific life time prevalence was highest among the age group of 15–19 years old [32.7 per 1000 persons (95% CI 29.1–36.8)] and it was higher in male (53.8%) than female (46.2%) participants. Our results showed that the life time prevalence of epilepsy in Iran is higher than worldwide average.
format	article
author	Hossein Pakdaman Ali Amini Harandi Koroush Gharagozli Farshid Alaeddini Akram Esfandani Seyed Hamidreza Mirbehbahani Taher Doroudi Pirhossein Kolivand Parviz Bahrami Hadi Kazemi
author_facet	Hossein Pakdaman Ali Amini Harandi Koroush Gharagozli Farshid Alaeddini Akram Esfandani Seyed Hamidreza Mirbehbahani Taher Doroudi Pirhossein Kolivand Parviz Bahrami Hadi Kazemi
author_sort	Hossein Pakdaman
title	Epilepsy lifetime prevalence in Iran: a large population- based national survey
title_short	Epilepsy lifetime prevalence in Iran: a large population- based national survey
title_full	Epilepsy lifetime prevalence in Iran: a large population- based national survey
title_fullStr	Epilepsy lifetime prevalence in Iran: a large population- based national survey
title_full_unstemmed	Epilepsy lifetime prevalence in Iran: a large population- based national survey
title_sort	epilepsy lifetime prevalence in iran: a large population- based national survey
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/9ddb771057bb4126859a047085d440bf
work_keys_str_mv	AT hosseinpakdaman epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT aliaminiharandi epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT koroushgharagozli epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT farshidalaeddini epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT akramesfandani epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT seyedhamidrezamirbehbahani epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT taherdoroudi epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT pirhosseinkolivand epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT parvizbahrami epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey AT hadikazemi epilepsylifetimeprevalenceiniranalargepopulationbasednationalsurvey
_version_	1718386189093830656

Epilepsy lifetime prevalence in Iran: a large population- based national survey

Ejemplares similares